Hydroxyamphetamine
Back to searchMolecule Structure
Scientific Name
Hydroxyamphetamine
Description of the Drug
Hydroxyamphetamine is an indirectly acting sympathomimetic agent producing mydriasis for diagnostic purposes.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09352
http://www.drugbank.ca/drugs/DB09352
Brand Name(s)
Not Available
Company Owner(s)
Akorn Operating Co Llc, Pharmics Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Adrenergic receptor | PROTEIN FAMILY | AGONIST | CHEMBL2331074 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL125440 | |
| Human Metabolome Database | HMDB0060765 | |
| DrugBank | DB09352 | |
| PubChem: Thomson Pharma | 15066381 | |
| PubChem | 3651 | |
| Mcule | MCULE-6999513658 | |
| NMRShiftDB | 60027261 | |
| LINCS | LSM-15206 | |
| Nikkaji | J182.169E | |
| BindingDB | 81459 | |
| EPA CompTox Dashboard | DTXSID3023134 | |
| DrugCentral | 1394 | |
| Brenda | 92409 | |
| rxnorm | HYDROXYAMPHETAMINE HYDROBROMIDE | P-HYDROXYAMPHETAMINE |
| ChEBI | 103855 |
